“…The great analytical performance of the magnetoimmunosensor, remarkably better than those reported before for other immunosensors (Table 4), the use of mass‐produced electrochemical transducers, together with meeting the criteria required for the unequivocal diagnosis of AMI, make the developed magnetoimmunosensor a useful and affordable analytical tool for clinical diagnosis and the development of POC devices for on‐site analysis of necrosis cardiac proteins. Following this work, an all cyclo‐olefin polymer (COP) based disposable microfluidic device, which is capable of capturing MBs and perform electrochemical detection in a series of Au electrodes, has been fabricated 36. The microfluidic device (Figure 6) was successfully applied to the determination of cTnT in the clinical relevant range from 0.05 to 1.0 ng mL −1 with a LOD of 0.03 ng mL −1 in buffer solutions.…”